Systems medicine: A real approach for future personalized oncology?

Pharmacogenomics

Volumn 11, Issue 3, 2010, Pages 283-287

  Roukos, Dimitrios H ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; CANCER GENETICS; CANCER STAGING; CANCER SURVIVAL; DNA SEQUENCE; EDITORIAL; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PHENOTYPE; PROGRESSION FREE SURVIVAL; SIGNAL TRANSDUCTION;

HUMANS; INDIVIDUALIZED MEDICINE; MEDICAL ONCOLOGY; NEOPLASMS; PHARMACOGENETICS; SYSTEMS BIOLOGY;

EID: 77949613884     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.36     Document Type: Editorial

References (19)

1. Schadt EE: Molecular networks as sensors and drivers of common human diseases. Nature 461(7261), 218-223 (2009).
2. Roukos DH: Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev. Mol. Diagn. 10(1), 33-48 (2010).
3. Deisboeck TS: Personalizing medicine: a systems biology perspective. Mol. Syst. Biol. 5, 249 (2009).
4. Roukos DH: Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev. Mol. Diagn. 9(3), 217-221 (2009).
5. Wood LD, Parsons DW, Jones S: The genomic landscapes of human breast and colorectal cancers. Science 318(5853), 1108-1113 (2007).
6. Jones S, Zhang X, Parsons DW: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897), 1801-1806 (2008).
7. Stratton MR, Campbell PJ, Futreal PA: The cancer genome. Nature 458(7239), 719-724 (2009).
8. Pleasance ED, Stephens PJ, O'Meara S et al.: A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463(7278), 184-190 (2009).
9. Pleasance ED, Cheetham RK, Stephens PJ et al.: A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463(7278), 191-196 (2010).
10. Shah SP, Morin RD, Khattra J et al.: Mutational evolution in a lobular breast tumour profled at single nucleotide resolution. Nature 461(7265), 809-813 (2009).
11. Stephens PJ, McBride DJ, Lin ML et al.: Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462(7276), 1005-1010 (2009).
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J. Clin. 59(4), 225-249 (2009).
13. Sargent D, Sobrero A, Grothey A et al.: Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J. Clin. Oncol. 27(6), 872-877 (2009).
14. van Cutsem E, Köhne CH, Hitre E et al.: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360(14), 1408-1417 (2009).
15. Ellis LM, Reardon DA: Cancer: the nuances of therapy. Nature 458(7236), 290-292 (2009).
16. Goldstein DB: 2020 visions. Personalized medicine. Nature 463, 27 (2010).
17. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2(5), 331-341 (2002).
18. Peterson RT: Drug discovery: propping up a destructive regime. Nature 461(7264), 599-600 (2009).
19. Bastiaens P: Systems biology: when it is time to die. Nature 459(7245), 334-335 (2009).